Literature DB >> 36131015

Unified rhombic lip origins of group 3 and group 4 medulloblastoma.

Kyle S Smith1, Laure Bihannic1, Brian L Gudenas1, Parthiv Haldipur2, Ran Tao1, Qingsong Gao1,3, Yiran Li1, Kimberly A Aldinger2, Igor Y Iskusnykh4, Victor V Chizhikov4, Matthew Scoggins5, Silu Zhang5, Angela Edwards5, Mei Deng6, Ian A Glass6, Lynne M Overman7, Jake Millman2, Alexandria H Sjoboen2, Jennifer Hadley1, Joseph Golser2, Kshitij Mankad8, Heather Sheppard3, Arzu Onar-Thomas9, Amar Gajjar10, Giles W Robinson10, Volker Hovestadt11, Brent A Orr3, Zoltán Patay5, Kathleen J Millen2, Paul A Northcott12.   

Abstract

Medulloblastoma, a malignant childhood cerebellar tumour, segregates molecularly into biologically distinct subgroups, suggesting that a personalized approach to therapy would be beneficial1. Mouse modelling and cross-species genomics have provided increasing evidence of discrete, subgroup-specific developmental origins2. However, the anatomical and cellular complexity of developing human tissues3-particularly within the rhombic lip germinal zone, which produces all glutamatergic neuronal lineages before internalization into the cerebellar nodulus-makes it difficult to validate previous inferences that were derived from studies in mice. Here we use multi-omics to resolve the origins of medulloblastoma subgroups in the developing human cerebellum. Molecular signatures encoded within a human rhombic-lip-derived lineage trajectory aligned with photoreceptor and unipolar brush cell expression profiles that are maintained in group 3 and group 4 medulloblastoma, suggesting a convergent basis. A systematic diagnostic-imaging review of a prospective institutional cohort localized the putative anatomical origins of group 3 and group 4 tumours to the nodulus. Our results connect the molecular and phenotypic features of clinically challenging medulloblastoma subgroups to their unified beginnings in the rhombic lip in the early stages of human development.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2022        PMID: 36131015     DOI: 10.1038/s41586-022-05208-9

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  66 in total

Review 1.  Medulloblastoma.

Authors:  Paul A Northcott; Giles W Robinson; Christian P Kratz; Donald J Mabbott; Scott L Pomeroy; Steven C Clifford; Stefan Rutkowski; David W Ellison; David Malkin; Michael D Taylor; Amar Gajjar; Stefan M Pfister
Journal:  Nat Rev Dis Primers       Date:  2019-02-14       Impact factor: 52.329

Review 2.  Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours.

Authors:  David T W Jones; Ana Banito; Thomas G P Grünewald; Michelle Haber; Natalie Jäger; Marcel Kool; Till Milde; Jan J Molenaar; Arash Nabbi; Trevor J Pugh; Gudrun Schleiermacher; Malcolm A Smith; Frank Westermann; Stefan M Pfister
Journal:  Nat Rev Cancer       Date:  2019-07-12       Impact factor: 60.716

Review 3.  Human Cerebellar Development and Transcriptomics: Implications for Neurodevelopmental Disorders.

Authors:  Parthiv Haldipur; Kathleen J Millen; Kimberly A Aldinger
Journal:  Annu Rev Neurosci       Date:  2022-04-19       Impact factor: 15.553

4.  Subtypes of medulloblastoma have distinct developmental origins.

Authors:  Paul Gibson; Yiai Tong; Giles Robinson; Margaret C Thompson; D Spencer Currle; Christopher Eden; Tanya A Kranenburg; Twala Hogg; Helen Poppleton; Julie Martin; David Finkelstein; Stanley Pounds; Aaron Weiss; Zoltan Patay; Matthew Scoggins; Robert Ogg; Yanxin Pei; Zeng-Jie Yang; Sonja Brun; Youngsoo Lee; Frederique Zindy; Janet C Lindsey; Makoto M Taketo; Frederick A Boop; Robert A Sanford; Amar Gajjar; Steven C Clifford; Martine F Roussel; Peter J McKinnon; David H Gutmann; David W Ellison; Robert Wechsler-Reya; Richard J Gilbertson
Journal:  Nature       Date:  2010-12-08       Impact factor: 49.962

Review 5.  Medulloblastomics revisited: biological and clinical insights from thousands of patients.

Authors:  Volker Hovestadt; Olivier Ayrault; Fredrik J Swartling; Giles W Robinson; Stefan M Pfister; Paul A Northcott
Journal:  Nat Rev Cancer       Date:  2019-12-09       Impact factor: 69.800

6.  Resolving medulloblastoma cellular architecture by single-cell genomics.

Authors:  Volker Hovestadt; Kyle S Smith; Laure Bihannic; Mariella G Filbin; McKenzie L Shaw; Alicia Baumgartner; John C DeWitt; Andrew Groves; Lisa Mayr; Hannah R Weisman; Alyssa R Richman; Marni E Shore; Liliana Goumnerova; Celeste Rosencrance; Robert A Carter; Timothy N Phoenix; Jennifer L Hadley; Yiai Tong; Jim Houston; Richard A Ashmun; Michael DeCuypere; Tanvi Sharma; Diane Flasch; Antonina Silkov; Keith L Ligon; Scott L Pomeroy; Miguel N Rivera; Orit Rozenblatt-Rosen; Jessica M Rusert; Robert J Wechsler-Reya; Xiao-Nan Li; Andreas Peyrl; Johannes Gojo; Dominik Kirchhofer; Daniela Lötsch; Thomas Czech; Christian Dorfer; Christine Haberler; Rene Geyeregger; Angela Halfmann; Charles Gawad; John Easton; Stefan M Pfister; Aviv Regev; Amar Gajjar; Brent A Orr; Irene Slavc; Giles W Robinson; Bradley E Bernstein; Mario L Suvà; Paul A Northcott
Journal:  Nature       Date:  2019-07-24       Impact factor: 49.962

7.  Childhood cerebellar tumours mirror conserved fetal transcriptional programs.

Authors:  Maria C Vladoiu; Ibrahim El-Hamamy; Laura K Donovan; Nada Jabado; Lincoln Stein; Michael D Taylor; Hamza Farooq; Borja L Holgado; Yogi Sundaravadanam; Vijay Ramaswamy; Liam D Hendrikse; Sachin Kumar; Stephen C Mack; John J Y Lee; Vernon Fong; Kyle Juraschka; David Przelicki; Antony Michealraj; Patryk Skowron; Betty Luu; Hiromichi Suzuki; A Sorana Morrissy; Florence M G Cavalli; Livia Garzia; Craig Daniels; Xiaochong Wu; Maleeha A Qazi; Sheila K Singh; Jennifer A Chan; Marco A Marra; David Malkin; Peter Dirks; Lawrence Heisler; Trevor Pugh; Karen Ng; Faiyaz Notta; Eric M Thompson; Claudia L Kleinman; Alexandra L Joyner
Journal:  Nature       Date:  2019-05-01       Impact factor: 49.962

8.  Stalled developmental programs at the root of pediatric brain tumors.

Authors:  Selin Jessa; Alexis Blanchet-Cohen; Brian Krug; Maria Vladoiu; Marie Coutelier; Damien Faury; Brice Poreau; Nicolas De Jay; Steven Hébert; Jean Monlong; W Todd Farmer; Laura K Donovan; Yixing Hu; Melissa K McConechy; Florence M G Cavalli; Leonie G Mikael; Benjamin Ellezam; Maxime Richer; Andréa Allaire; Alexander G Weil; Jeffrey Atkinson; Jean-Pierre Farmer; Roy W R Dudley; Valerie Larouche; Louis Crevier; Steffen Albrecht; Mariella G Filbin; Hervé Sartelet; Pierre-Eric Lutz; Corina Nagy; Gustavo Turecki; Santiago Costantino; Peter B Dirks; Keith K Murai; Guillaume Bourque; Jiannis Ragoussis; Livia Garzia; Michael D Taylor; Nada Jabado; Claudia L Kleinman
Journal:  Nat Genet       Date:  2019-11-25       Impact factor: 38.330

9.  Spatial and cell type transcriptional landscape of human cerebellar development.

Authors:  Kimberly A Aldinger; Zachary Thomson; Ian G Phelps; Parthiv Haldipur; Mei Deng; Andrew E Timms; Matthew Hirano; Gabriel Santpere; Charles Roco; Alexander B Rosenberg; Belen Lorente-Galdos; Forrest O Gulden; Diana O'Day; Lynne M Overman; Steven N Lisgo; Paula Alexandre; Nenad Sestan; Dan Doherty; William B Dobyns; Georg Seelig; Ian A Glass; Kathleen J Millen
Journal:  Nat Neurosci       Date:  2021-06-17       Impact factor: 28.771

10.  Spatiotemporal expansion of primary progenitor zones in the developing human cerebellum.

Authors:  Parthiv Haldipur; Kimberly A Aldinger; Silvia Bernardo; Mei Deng; Andrew E Timms; Lynne M Overman; Conrad Winter; Steven N Lisgo; Ferechte Razavi; Evelina Silvestri; Lucia Manganaro; Homa Adle-Biassette; Fabien Guimiot; Rosa Russo; Debora Kidron; Patrick R Hof; Dianne Gerrelli; Susan J Lindsay; William B Dobyns; Ian A Glass; Paula Alexandre; Kathleen J Millen
Journal:  Science       Date:  2019-10-17       Impact factor: 47.728

View more
  1 in total

Review 1.  Human cerebral organoids - a new tool for clinical neurology research.

Authors:  Oliver L Eichmüller; Juergen A Knoblich
Journal:  Nat Rev Neurol       Date:  2022-10-17       Impact factor: 44.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.